Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 8105-8105
Author(s):  
D. B. Costa ◽  
B. C. Cho ◽  
L. V. Sequist ◽  
G. J. Riely ◽  
B. Halmos ◽  
...  
Keyword(s):  
Acquired Resistance ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Egfr Mutated

scholarly journals Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

Lung Cancer ◽  
2015 ◽  
Vol 88 (1) ◽  
pp. 108-111 ◽  
Author(s):  
Deepa Rangachari ◽  
Norihiro Yamaguchi ◽  
Paul A. VanderLaan ◽  
Erik Folch ◽  
Anand Mahadevan ◽  
...  
Keyword(s):  
Brain Metastases ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Egfr Mutated

scholarly journals Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

2008 ◽  
Vol 14 (21) ◽  
pp. 7060-7067 ◽  
Author(s):  
Daniel B. Costa ◽  
Kim-Son H. Nguyen ◽  
Byoung C. Cho ◽  
Lecia V. Sequist ◽  
David M. Jackman ◽  
...  
Keyword(s):  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Egfr Mutated
Sign in / Sign up

Export Citation Format

Share Document